학술논문
MA07.03 Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)
Document Type
Abstract
Author
Kim, Young; Hida, Toyoaki; Nokihara, Hiroshi; Kondo, Masashi; Azuma, Koichi; Seto, Takashi; Takiguchi, Yuichi; Nishio, Makoto; Yoshioka, Hiroshige; Imamura, Fumio; Hotta, Katsuyuki; Watanabe, Satoshi; Goto, Koichi; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Yamamoto, Nobuyuki; Kuriki, Hiroshi; Asabe, Ryoichi; Tanaka, Tomohiro; Tamura, Tomohide
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S378-S379
Subject
Language
ISSN
1556-0864